EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Normal corneal endothelial development is preserved during pediatric daily disposable omafilcon A soft contact lens wear

David Hammond, Katie Harrop, Sayuri Ninomiya, Kaori Inazawa, Yasutaka Kubota, Kathryn Richdale, Kazuya Isozaki, Nobuko Misumi

Optometry and Vision Science · 2026-11 · 103 (11)

DOI: 10.1002/ovs2.70106 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Purpose Corneal health during pediatric soft contact lens wear remains an important consideration in myopia management. This study evaluated longitudinal changes in endothelial cell density (ECD) and morphology in children participating in the Japan MiSight 1 day clinical trial. Methods A total of 60 subjects (mean age 10.4 ± 1.3 years at baseline) contributed 470 longitudinal endothelial measurements over 2 years. All subjects were wearing daily disposable omafilcon A soft contact lenses, including the dual focus MiSight 1 day myopia control and single vision Proclear 1 day designs. Subjects underwent specular microscopy measurements and data were analyzed using linear mixed‐effects models. Results ECD decreased at a rate of −20.4 cells/mm 2 per year ( p = 0.001), accompanied by an increase in the coefficient of variation (+1.10% per year, p < 0.001) and no significant change in percentage of hexagonal cells (−0.42% per year, p = 0.098). The observed rate of ECD decline was similar to that reported in a large normative dataset of ophthalmologically healthy Japanese individuals (−19.3 cells/mm 2 per year), with the normative estimate falling within the 95% confidence interval of the present study estimate. No differences were observed between the MiSight 1 day and Proclear 1 day groups for any endothelial parameter. Conclusions These findings are consistent with daily disposable omafilcon A soft contact lens wear not altering the normal age‐related trajectory of corneal endothelial change in children and support preservation of the endothelial structure during pediatric contact lens use. Clinical Trial Registration Japan Registry of Clinical Trials (jRCT2052210116).

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →